Melatonin inhibits the expression of vascular endothelial growth factor in pancreatic cancer cells

Chinese Journal of Cancer Research

Volumn 24, Issue 4, 2012, Pages 310-316

  Lv, Dong ^a   Cui, Pei Lin ^a   Yao, Shi Wei ^a   Xu, You Qing ^a   Yang, Zhao Xu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Melatonin; pancreatic cancer; VEGF

Indexed keywords

MELATONIN; MESSENGER RNA; VASCULOTROPIN;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INCUBATION TIME; PANCREAS CARCINOMA; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT;

EID: 84875442654     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.1007/s11670-012-0269-6     Document Type: Article

References (35)

1. Schönau KK, Steger GG, Mader RM. Angiogenic effect of naive and 5-fluorouracil resistant colon carcinoma on endothelial cells in vitro. Cancer Lett 2007;257:73-78.
2. Niedergethmann M, Alves F, Neff JK, et al. Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model. Br J Cancer 2007;97:1432-1440.
3. Xie K, Wei D, Huang S. Transcriptional anti-angiogenesis therapy of human pancreatic cancer. Cytokine Growth Factor Rev 2006;17:147-156.
4. Thurston G, Kitajewski J. VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis. Br J Cancer 2008;99:1204-1209.
5. Doi Y, Yashiro M, Yamada N, et al. Significance of phosphovascular endothelial growth factor receptor-2 expression in pancreatic cancer. Cancer Sci 2010;101:1529-1535.
6. Liang QL, Wang BR, Chen GQ, et al. Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters. Med Oncol 2010;27:1164-1170.
7. Li K, Li MJ, He T, et al. Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis. Zhonghua Yi Xue Za Zhi 2009;89:2386-2390.
8. Ochi N, Matsuo Y, Sawai H, et al. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis. Pancreas 2007;34:444-451.
9. Reiter RJ. Mechanisms of cancer inhibition by melatonin. J Pineal Res 2004;37:213-214.
10. Sainz RM, Mayo JC, Rodriguez C, et al. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 2003;60:1407-1426.
11. Cabrera J, Negrín G, Estévez F, et al. Melatonin decreases cell proliferation and induces melanogenesis in human melanoma SK-MEL-1 cells. J Pineal Res 2010;49:45-54.
12. Lissoni P, Rovelli F, Malugani F, et al. Anti-angiogenic activity of melatonin in advanced cancer patients. Neuro Endocrinol Lett 2001;22:45-47.
13. Dai M, Cui P, Yu M, et al. Melatonin modulates the expression of VEGF and HIF-1 alpha induced by CoCl2 in cultured cancer cells. J Pineal Res 2008;44:121-126.
14. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
15. Cook KM, Figg WD. Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin 2010;60:222-243.
16. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
17. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005;69Suppl 3:4-10.
18. Gupta MK, Qin RY. Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol 2003;9:1144-1155.
19. Saif MW. Anti-angiogenesis therapy in pancreatic carcinoma. JOP 2006;7:163-173.
20. Turner HE, Harris AL, Melmed S, et al. Angiogenesis in endocrine tumors. Endocr Rev 2003;24:600-632.
21. Reiter RJ, Tan DX, Erren TC, et al. Light-mediated perturbations of circadian timing and cancer risk: a mechanistic analysis. Integr Cancer Ther 2009;8:354-360.
22. Carrillo-Vico A, Guerrero JM, Lardone PJ, et al. A review of the multiple actions of melatonin on the immune system. Endocrine 2005;27:189-200.
23. Carbajo-Pescador S, García-Palomo A, Martín-Renedo J, et al. Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor. J Pineal Res 2011;51:463-471.
24. Vijayalaxmi, Thomas CR Jr, Reiter RJ, et al. Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 2002;20:2575-2601.
25. Cui P, Luo Z, Zhang H, et al. Effect and mechanism of melatonin's action on the proliferation of human umbilical vein endothelial cells. J Pineal Res 2006;41:358-362.
26. Cui P, Yu M, Luo Z, et al. Intracellular signaling pathways involved in cell growth inhibition of human umbilical vein endothelial cells by melatonin. J Pineal Res 2008;44:107-114.
27. Di Nicola M, Anichini A, Mortarini R, et al. Human dendritic cells: natural adjuvants in antitumor immunotherapy. Cytokines Cell Mol Ther 1998;4:265-273.
28. Silva SO, Ximenes VF, Livramento JA, et al. High concentrations of the melatonin metabolite, N1-acetyl-N2-formyl-5-methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism. J Pineal Res 2005;39:302-306.
29. Sutherland ER, Martin RJ, Ellison MC, et al. Immunomodulatory effects of melatonin in asthma. Am J Respir Crit Care Med 2002;166:1055-1061.
30. Cho SY, Lee HJ, Jeong SJ, et al. Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells.J Pineal Res 2011;51:87-93.
31. Zhang D, Li B, Shi J, et al. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein. Cancer Res 2010;70:2495-2503.
32. Cui P, Yu M, Peng X, et al. Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression. J Pineal Res 2012;52:236-243.
33. Pawlikowski M, Winczyk K, Karasek M. Oncostatic action of melatonin: facts and question marks. Neuro Endocrinol Lett 2002;23:24-29.
34. García-Santos G, Antolín I, Herrera F, et al. Melatonin induces apoptosis in human neuroblastoma cancer cells. J Pineal Res 2006;41:130-135.
35. Weinreb O, Mandel S, Youdim MB. cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells. FASEB J 2003;17:935-937.